A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee.
Carver
V
V
Division of Clinical Pharmacology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Coyle
B
B
Koren
G
G
Lavigne
S
S
Martinez
L
L
Robertson
J
J
Polifka
J
J
Stepanuk
K
K
D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control*; D000328:Adult; D000075202:Contraindications; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D014943:Global Health; D006801:Humans; D007255:Information Services; D015474:Isotretinoin / Q000009:adverse effects*; D016134:Organizational Policy; D011247:Pregnancy; D012958:Societies, Scientific; D018600:Teratology; D014481:United States
D003879:Dermatologic Agents; D015474:Isotretinoin